For an advanced lifter whose protein and energy intake are already dialed in, the scientific evidence for omega-3 fatty acids splits cleanly along two lines. The case that omega-3s—specifically EPA and DHA—can help manage exercise-induced inflammation, muscle damage, and soreness is reasonably supported and dose-dependent. The case that they directly build muscle mass or strength in well-nourished athletes is, in the words of sports scientists Oliver Witard and Jon-Kyle Davis writing for the Gatorade Sports Science Institute, "weak at present, at least if the athlete follows standard sports nutrition guidelines to support muscle building, e.g., a positive energy balance and sufficient dietary protein intake."
That distinction is the whole story for this population. Omega-3s are essential nutrients the body cannot produce in needed amounts, as the American Society for Nutrition notes, and a review in Advances in Nutrition found supplementation "may lead to very small increases in muscle strength." But "may lead to very small increases" is not a hypertrophy strategy. What follows explains the proposed mechanisms, where the recovery evidence actually stands, and how to decide whether supplementation fits your goals.
Key Mechanisms: How Omega-3s Influence Muscle Physiology
Skeletal muscle is constantly remodeled through the simultaneous processes of muscle protein synthesis and muscle protein breakdown, together termed muscle protein turnover. The anabolic hypothesis for omega-3s centers on sensitizing the synthesis side of that equation to amino acids. A review of muscle protein turnover by Chris McGlory, Philip Calder, and Everson Nunes, published in Frontiers in Nutrition in 2019, traces the research lineage: fish oils rich in EPA and DHA showed effects on muscle in rodent cancer-cachexia models, and later human reports corroborated some of those findings, including an association between low skeletal muscle mass and reduced plasma EPA status in cancer patients.
One proposed mechanism for the potentiation of muscle protein synthesis with feeding, discussed in that same review, involves changes in mTORC1–lysosomal interactions. Work using immunohistochemical approaches has demonstrated that mTOR localization to lysosomal and cell membranes is a key step in mTORC-1 activation, and presumably in muscle protein synthesis in response to amino acid provision. This integration of omega-3s into cell membranes is a proposed mechanism for their broader physiological effects rather than a settled fact.
A critical caveat comes from the GSSI review: evaluating omega-3s' role in training adaptation and recovery "must primarily rely on extrapolating data from studies in recreationally trained or untrained humans, as well as animal studies and experiments conducted in cell culture." The mechanistic picture, in other words, is built substantially on populations and models that are not advanced athletes.
